This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
Interventions
The strategies were the classic 'cut and sew' maze procedure; high-intensity focused ultrasound (HIFU)-assisted surgical ablation; and percutaneous ablation, all concomitant with cardiac surgery. These strategies were compared with noninterventional, drug treatment.
Location/setting
UK/secondary care and hospital.
Methods

Analytical approach:
This economic evaluation was based on a Markov model with a five-year time horizon. The authors stated that the perspective of the National Health Service (NHS) was taken.
Effectiveness data:
The clinical data were identified through a literature review of clinical trials in the Medline database. The trials that were selected were those that provided the most appropriate treatment effect data, which could be used without too many adaptations. The authors provided details on the number of patients and the results of the trials selected. The longterm mortality was taken from a prospective cohort study and UK life tables. The key clinical input was the treatment effect and the recurrence rate for AF.
Monetary benefit and utility valuations:
The utility valuations for AF were based on the European Quality of life (EQ-5D) questionnaire and provided by the European Heart Survey investigators. The utility weights for other health states were taken from a published metaanalysis that used a time trade-off method to elicit preferences.
Measure of benefit:
Quality-adjusted life-years (QALYs) were used as the summary benefit measure and they were discounted at an annual rate of 3.5%.
